TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors
DENVER -- The University of Texas MD Anderson Cancer Center and Denver-based TriSalus Life Sciences announced a strategic research collaboration to evaluate the treatment of tumors of the... Read More
Thursday April 15, 2021
TriSalus Life Sciences appoints Steven Katz as chief medical officer
DENVER -- TriSalus Life Sciences announced the appointment of Steven Katz , M.D., as its chief medical officer. Katz will oversee the company’s clinical development strategy as it seeks to... Read More
Monday October 5, 2020
TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate
DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More
Monday September 28, 2020
IN Sponsors
Browse
Entrepreneurial by Nature
